Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
2.800
-0.040 (-1.41%)
Aug 29, 2025, 4:00 PM - Market closed

Jasper Therapeutics Stock Forecast

JSPR's stock price has decreased by -85.96% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 9 analysts that cover Jasper Therapeutics stock have a consensus rating of "Buy" and an average price target of $30.78, which forecasts a 999.29% increase in the stock price over the next year. The lowest target is $4.00 and the highest is $65.

Price Target: $30.78 (+999.29%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$4.00$30.78$20$65
Change+42.86%+999.29%+614.29%+2221.4%

Analyst Ratings

The average analyst rating for Jasper Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy444433
Buy777766
Hold000033
Sell000000
Strong Sell000000
Total111111111212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Maintains
$29$25
Strong BuyMaintains$29$25+792.86%Aug 15, 2025
BMO Capital
BMO Capital
Hold
Downgrades
$15$4
HoldDowngrades$15$4+42.86%Jul 8, 2025
JMP Securities
JMP Securities
Buy
Maintains
$70$12
BuyMaintains$70$12+328.57%Jul 8, 2025
Evercore ISI Group
Evercore ISI Group
Buy
Maintains
$50$20
BuyMaintains$50$20+614.29%Jul 8, 2025
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.10
from -4.89
EPS Next Year
-3.75
from -5.10
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-183.08-26.89-10.33-6.18-4.89-5.10-3.75
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1212
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-3.78-1.41
Avg-5.10-3.75
Low-5.84-5.83

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.